Wells Fargo’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Buy |
31,757
+4,874
| +18% | +$65.9K | ﹤0.01% | 3889 |
|
|
2025
Q1 | $427K | Buy |
26,883
+3,169
| +13% | +$50.3K | ﹤0.01% | 3784 |
|
|
2024
Q4 | $292K | Buy |
23,714
+3,802
| +19% | +$46.8K | ﹤0.01% | 4071 |
|
|
2024
Q3 | $241K | Buy |
19,912
+221
| +1% | +$2.68K | ﹤0.01% | 4073 |
|
|
2024
Q2 | $230K | Buy |
19,691
+5,268
| +37% | +$61.6K | ﹤0.01% | 4076 |
|
|
2024
Q1 | $186K | Buy |
14,423
+6,405
| +80% | +$82.7K | ﹤0.01% | 4151 |
|
|
2023
Q4 | $69K | Buy |
8,018
+3,083
| +62% | +$26.5K | ﹤0.01% | 4716 |
|
|
2023
Q3 | $46.9K | Sell |
4,935
-1,388
| -22% | -$13.2K | ﹤0.01% | 4864 |
|
|
2023
Q2 | $108K | Buy |
6,323
+3,987
| +171% | +$68K | ﹤0.01% | 4723 |
|
|
2023
Q1 | $36.6K | Buy |
+2,336
| New | +$36.6K | ﹤0.01% | 5037 |
|